<DOC>
	<DOCNO>NCT00157378</DOCNO>
	<brief_summary>The study multicenter , double-blind , randomize , parallel-group study first episode schizophrenic patient . During treatment phase 8 week patient treat Risperidone Haloperidol . Aim project compare effect atypical neuroleptic Risperidone conventional neuroleptic Haloperidol evaluate whether assumed advantage atypical neuroleptic compare conventional neuroleptic also present medication administer rather low daily dosage ( min . 2 mg/d ; max . 8 mg/d ) .</brief_summary>
	<brief_title>Optimization Acute Treatment First Episode Schizophrenia</brief_title>
	<detailed_description>Considering first episode schizophrenic patient compare multiple episode patient respond low dosage neuroleptic , study aim reach neuroleptic response low possible dosage study medication ( haloperidol risperidone ) . Therefore initial dosage study medication 2 mg/d . Depending patient ` symptomatology , daily dosage study medication increase 2 mg weekly interval maximum dosage 8 mg/d . Patients diagnosis schizophrenia ( F20 , accord ICD-10-criteria ) consecutively enrol study . The patient assess weekly interval acute inpatient treatment phase 8 week . Apart weekly psychopathological characterisation additionally neuropsychobiological data assess time admission end study . Major question study , whether patient , treat risperidone compare , treat haloperidol show well treatment outcome regard negative symptom exhibit few extra-pyramidal motor side effect . Furthermore hypothesised , treatment Risperidone good effect cognitive disorders/dysfunctions depressive symptom patient , receive Risperidone compliant high quality life .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Haloperidol</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<criteria>ICD10 criterion first episode schizophrenia age 18 55 informed consent legal reason insufficient knowledge german language substance abuse addiction pregnancy serious physical illness organic brain disease contraindication neuroleptic treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2000</verification_date>
	<keyword>first episode ,</keyword>
	<keyword>schizophrenia ,</keyword>
	<keyword>atypical neuroleptic ,</keyword>
	<keyword>negative symptom</keyword>
</DOC>